CF · CF Industries Holdings, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 12-month Rolling Average Recordable Incident Rate | 0.16 | 12-month rolling average as of June 30, 2026 | — |
| 1H 2026 Available Ammonia Capacity Utilization | 98% | 1H 2026 | — |
| 5-year rolling avg. percent of capacity utilization (CF North America) | 96% | 5-year rolling average ending 2025 | — |
| 5-year rolling avg. percent of capacity utilization (North America Excluding CF) | 86% | 5-year rolling average ending 2025 | — |
| Adjusted EBITDA non-GAAP | $2.18B | First Half 2026 | — |
|
|
|||
| Available Ammonia Capacity Utilization | 98% | First Half 2026 | — |
| Average cost of natural gas used for production in cost of sales | $4.01 | First Half 2026 | — |
| EBITDA non-GAAP | $2.17B | First Half 2026 | — |
|
|
|||
| Gross ammonia production | 4.9M | First Half 2026 | — |
|
|
|||
| Q2 2026 Adjusted EBITDA non-GAAP | $1.2B | Q2 2026 | — |
| Q2 2026 LTM Adjusted EBITDA non-GAAP | $3.7B | Q2 2026 LTM | — |
| Q2 2026 LTM Capital Returned to Shareholders | $1.3B | Q2 2026 LTM | — |
| Q2 2026 LTM FCF/Adj EBITDA Conversion non-GAAP | 50% | Q2 2026 LTM | — |
| Q2 2026 LTM Free Cash Flow non-GAAP | $1.8B | Q2 2026 LTM | — |
| Remaining in Current $2B Share Repurchase Authorization | $1.48B | As of June 30, 2026 | — |
| Sales volume by product tons | 8.94M | First Half 2026 | — |
|
|
|||
| Shares repurchased | 2.2M | First Half 2026 | — |
| Total Capital Expenditures | $494M | First Half 2026 | — |
|
|
|||
| 2012 CF gross ammonia capacity | 7.3M | 2012 | — |
| 2025 CF gross ammonia capacity | 10.5M | 2025 | — |
| CF Industries' trailing 5-year average ammonia production | 9.5M | trailing 5-year average | — |
| Q1 2026 Adjusted EBITDA non-GAAP | $983M | Q1 2026 | — |
| Q1 2026 Available Ammonia Capacity Utilization | 99% | Q1 2026 | — |
| Q1 2026 LTM Adjusted EBITDA non-GAAP | $3.2B | Q1 2026 LTM | — |
| Q1 2026 LTM Capital Returned to Shareholders | $1.3B | Q1 2026 LTM | — |
| Q1 2026 LTM FCF/Adj EBITDA Conversion non-GAAP | 51% | Q1 2026 LTM | — |
| Q1 2026 LTM Free Cash Flow non-GAAP | $1.7B | Q1 2026 LTM | — |
| Capacity Utilization | 97% | FY 2025 | — |
| Capital Returned to Shareholders | $1.7B | FY 2025 | — |
| FCF/Adj EBITDA Conversion non-GAAP | 62% | FY 2025 | — |
| Free cash flow non-GAAP | $1.79B | Full year 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities 2.75B
-950M Capital expenditures
-304M Distributions to noncontrolling interests
+291M Contributions from noncontrolling interests
= Free cash flow 1.79B
|
|||
| Recordable Incident Rate | 0.26 | FY 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CF
this stock
CF Industries Holdings, Inc.
|
$17.90B | +53.0% | +19.3% | 8.8 | 5.3% |
|
CTVA
Corteva, Inc.
|
$51.16B | +14.4% | +2.9% | 50.1 | 2.7% |
|
NTR
Nutrien Ltd.
|
$32.56B | +10.6% | — | — | 0.8% |
|
YARIY
Yara International ASA
|
$11.30B | +8.8% | — | — | 0.0% |
|
ICL
ICL Group Ltd.
|
$6.89B | -2.8% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CF | +3.5% | -2.6% | +23.9% | -5.5% | +53.0% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +3.1% | -7.0% | +10.2% | -9.4% | +39.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.